This is a recognized mechanism of action for weight loss, but the previous class of such experimental drugs was abandoned due to potential neuropsychiatric adverse event risks. CRB-913 is a member of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback